Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Somboon, Tansuphasawadikul"'
Autor:
Somboon Tansuphasawadikul, David A. Cooper, Umaporn Siangphoe, Phitsanu Raksakulkarn, Kiat Ruxrungtham, Andrew F. Hill, Warangkana Munsakul, Sasisopin Kiertiburanakul, Ploenchan Chetchotisakd, Reto Nüesch, Wisit Prasithsirikul, Bernard Hirschel, Jintanat Ananworanich
Publikováno v:
Scopus-Elsevier
Antiviral Therapy, Vol. 10, No 6 (2005) pp. 761-767
Antiviral Therapy, Vol. 10, No 6 (2005) pp. 761-767
ObjectiveTo assess the efficacy and safety of first-line treatment with once-daily saquinavir/ritonavir with two nucleoside reverse transcriptase inhibitors (NRTIs), as induction therapy before enrollment in a randomized trial of structured treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::becab3677e68c31cacbca2af440353cf
https://doi.org/10.1177/135965350501000604
https://doi.org/10.1177/135965350501000604
Autor:
Somboon, Tansuphasawadikul, Songchai, Simaroj, Somchai, Chantarothorn, Nontakan, Nuntachit, Kamonwan, Jutivorakool, Warangkana, Munsakul, Kanittha, Yomtem, Thitirat, Tangkosakul, Suppaleark, Wannasunthornchai
Publikováno v:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 94(2)
Meropenem plays a significant role in the current antimicrobial treatment of serious infections. Recently, generic meropenems have become widely available in Thailand.Compare the effectiveness and safety ofa generic meropenem (Mapenem) with the origi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d5666c2d9f84bea260496c9565ca5885
https://pubmed.ncbi.nlm.nih.gov/21534363
https://pubmed.ncbi.nlm.nih.gov/21534363
Autor:
Jintanat, Ananworanich, Angele, Gayet-Ageron, Kiat, Ruxrungtham, Ploenchan, Chetchotisakd, Wisit, Prasithsirikul, Sasisopin, Kiertiburanakul, Warangkana, Munsakul, Phitsonu, Raksakulkarn, Somboon, Tansuphasawadikul, Michelle, LeBraz, Thidarat, Jupimai, Sasiwimol, Ubolyam, Malte, Schutz, Bernard, Hirschel
Publikováno v:
Antiviral Therapy, Vol. 13, No 3 (2008) pp. 375-380
BACKGROUND: The aim of this study was to assess the long-term efficacy and safety of first-line treatment with once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors (NRTIs). METHODS: A total of 272 antiretroviral-naive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ba5563a5d63e1cbd8a1b5b540be0b371
https://archive-ouverte.unige.ch/unige:7078
https://archive-ouverte.unige.ch/unige:7078
Autor:
Sasisopin Kiertiburanakul, Jintanat Ananworanich, Ploenchan Chetchotisakd, Phitsanu Raksakulkarn, Wisit Prasithsirikul, Sasiwimol Ubolyam, Bernard Hirschel, Somboon Tansuphasawadikul, Kiat Ruxrungtham, Warangkana Munsakul, Wendy Snowden, Malte Schutz, Sunee Sirivichayakul, Thidarat Jupimai
Publikováno v:
Antiviral therapy, 11(5), 631-635. International Medical Press Ltd
Antiviral Therapy, Vol. 11, No 5 (2006) pp. 631-635
Antiviral Therapy, Vol. 11, No 5 (2006) pp. 631-635
BackgroundThere are few data on the selection of resistance by ritonavir-boosted saquinavir (SQV/r), particularly in antiretroviral (ARV)-naive patients.ObjectiveTo assess the incidence of virological failure and evolution of resistance in ARV-naive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b30001415b04b180aa5d6c23007966a5
https://pure.amc.nl/en/publications/absence-of-resistance-mutations-in-antiretroviralnaive-patients-treated-with-ritonavirboosted-saquinavir(937332ee-c397-4b29-b5b0-a014a2da870f).html
https://pure.amc.nl/en/publications/absence-of-resistance-mutations-in-antiretroviralnaive-patients-treated-with-ritonavirboosted-saquinavir(937332ee-c397-4b29-b5b0-a014a2da870f).html